BIOMARIN PHARMACEUTICAL INC
BMRNNASDAQ🏆 #803 by market capEarnings Oct 26US Equity
$59.87▲ $0.41 (+0.69%)
🌙 After hours$59.87▲ 0.00%Regular close · extended-hours price shownTrack BMRN
Get earnings, price moves & breaking news on Telegram
24h▲ 0.7%
7d▼ 5.6%
14d▼ 7.1%
30d▼ 7.4%
ytd▲ 0.7%
1y▲ 10.8%
🏦Market Cap
$11.57B
Mid Cap
📈Revenue Growth (YoY)
+12.9%
Healthy
📊Gross Margin
75.5%
High
💵FCF Margin
21.5%
Strong
⚖️P/S Ratio
3.4x
Fair
Otter Score
60
Fair
BIOMARIN PHARMACEUTICAL INC
BMRNAnalyst Ratings
Price
$59.87
Total
41
Raised
0
Lowered
6
Avg PT
$90.88
H / L
$124 / $59
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Neutral | 2026-09-10 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-09-01 | $90.00 | +50.30% |
Jefferies | Reiterated | Buy | 2026-08-31 | $105.00 | +75.40% |
BMO Capital | Reiterated | Outperform | 2026-08-19 | $97.00 | +62.00% |
Barclays | Reiterated | Overweight | 2026-08-17 | $111.00 | +85.40% |
Canaccord Genuity | Reiterated | Buy | 2026-08-10 | $114.00 | +90.40% |
Morgan Stanley | Reiterated | Overweight | 2026-08-07 | $124.00 | +107.10% |
Oppenheimer | Reiterated | Outperform | 2026-08-07 | $97.00 | +62.00% |
Citigroup | Reiterated | Buy | 2026-07-16 | $81.00 | +35.30% |
RBC Capital | Reiterated | Sector Perform | 2026-07-07 | $62.00 | +3.60% |
B of A Securities | Reiterated | Buy | 2026-05-19 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-05-05 | — | — |
Bernstein | Reiterated | Outperform | 2026-05-05 | $88.00 | +47.00% |
Freedom Broker | Reiterated | Buy | 2026-03-02 | — | — |
Guggenheim | Reiterated | Buy | 2026-02-25 | $120.00 | +100.40% |
Wells Fargo | Reiterated | Overweight | 2026-02-18 | $75.00 | +25.30% |
Truist Securities | Reiterated | Buy | 2025-12-23 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-12-03 | $62.00 | +3.60% |
Stifel | Downgraded | Buy → Hold | 2025-11-06 | — | — |
JP Morgan | Reiterated | Overweight | 2025-10-09 | — | — |
UBS | Reiterated | Buy | 2025-08-05 | $88.00 | +47.00% |
Goldman Sachs | Reiterated | Buy | 2025-05-05 | $69.00 | +15.20% |
Scotiabank | Reiterated | Sector Perform | 2025-02-20 | $78.00 | +30.30% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-02-20 | $86.00 | +43.60% |
William Blair | Downgraded | Outperform → Market Perform | 2024-10-30 | — | — |
Baird | Reiterated | Neutral | 2024-10-30 | — | — |
TD Cowen | Reiterated | Buy | 2024-08-06 | — | — |
Wedbush | Reiterated | Neutral | 2023-08-01 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-04-27 | $105.00 | +75.40% |
SVB Leerink | Reiterated | Outperform | 2023-02-03 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-06-18 | — | — |
Nomura | Reiterated | Neutral | 2019-10-24 | — | — |
Raymond James | Downgraded | Market Outperform → Market Perform | 2019-01-02 | $109.00 | +82.10% |
Stifel Nicolaus | Reiterated | Buy | 2018-08-03 | $70.00 | +16.90% |
Leerink Swann | Reiterated | Outperform | 2018-02-23 | — | — |
Deutsche Bank | Reiterated | Buy | 2018-02-23 | — | — |
PiperJaffray | Downgraded | Overweight → Neutral | 2016-11-07 | — | — |
Bank of America | Reiterated | Buy | 2015-08-04 | — | — |
Janney Capital | Reiterated | Buy | 2013-01-02 | — | — |
Brean Capital | Downgraded | Buy → Hold | 2012-11-06 | — | — |
ThinkEquity | Reiterated | Buy | 2012-06-29 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Neutral · 2026-09-10
—
—
Piper Sandler
Reiterated · Overweight · 2026-09-01
$90.00
+50.30%
Jefferies
Reiterated · Buy · 2026-08-31
$105.00
+75.40%
BMO Capital
Reiterated · Outperform · 2026-08-19
$97.00
+62.00%
Barclays
Reiterated · Overweight · 2026-08-17
$111.00
+85.40%
Canaccord Genuity
Reiterated · Buy · 2026-08-10
$114.00
+90.40%
Morgan Stanley
Reiterated · Overweight · 2026-08-07
$124.00
+107.10%
Oppenheimer
Reiterated · Outperform · 2026-08-07
$97.00
+62.00%
Citigroup
Reiterated · Buy · 2026-07-16
$81.00
+35.30%
RBC Capital
Reiterated · Sector Perform · 2026-07-07
$62.00
+3.60%
B of A Securities
Reiterated · Buy · 2026-05-19
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-05-05
—
—
Bernstein
Reiterated · Outperform · 2026-05-05
$88.00
+47.00%
Freedom Broker
Reiterated · Buy · 2026-03-02
—
—
Guggenheim
Reiterated · Buy · 2026-02-25
$120.00
+100.40%
Wells Fargo
Reiterated · Overweight · 2026-02-18
$75.00
+25.30%
Truist Securities
Reiterated · Buy · 2025-12-23
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-12-03
$62.00
+3.60%
Stifel
Downgraded · Buy → Hold · 2025-11-06
—
—
JP Morgan
Reiterated · Overweight · 2025-10-09
—
—
UBS
Reiterated · Buy · 2025-08-05
$88.00
+47.00%
Goldman Sachs
Reiterated · Buy · 2025-05-05
$69.00
+15.20%
Scotiabank
Reiterated · Sector Perform · 2025-02-20
$78.00
+30.30%
Cantor Fitzgerald
Reiterated · Overweight · 2025-02-20
$86.00
+43.60%
William Blair
Downgraded · Outperform → Market Perform · 2024-10-30
—
—
Baird
Reiterated · Neutral · 2024-10-30
—
—
TD Cowen
Reiterated · Buy · 2024-08-06
—
—
Wedbush
Reiterated · Neutral · 2023-08-01
—
—
Credit Suisse
Reiterated · Outperform · 2023-04-27
$105.00
+75.40%
SVB Leerink
Reiterated · Outperform · 2023-02-03
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-06-18
—
—
Nomura
Reiterated · Neutral · 2019-10-24
—
—
Raymond James
Downgraded · Market Outperform → Market Perform · 2019-01-02
$109.00
+82.10%
Stifel Nicolaus
Reiterated · Buy · 2018-08-03
$70.00
+16.90%
Leerink Swann
Reiterated · Outperform · 2018-02-23
—
—
Deutsche Bank
Reiterated · Buy · 2018-02-23
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2016-11-07
—
—
Bank of America
Reiterated · Buy · 2015-08-04
—
—
Janney Capital
Reiterated · Buy · 2013-01-02
—
—
Brean Capital
Downgraded · Buy → Hold · 2012-11-06
—
—
ThinkEquity
Reiterated · Buy · 2012-06-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space